One-liner#

Evaluate unintentional or concerning weight gain by identifying secondary causes (medications, hypothyroidism, Cushing’s) while recognizing that most cases are due to energy imbalance; offer evidence-based treatment including lifestyle, medications, and referral for bariatric surgery when appropriate.

Quick nav#

• Red flags / send to ED
• Key history
• Focused exam
• Differential (quick pattern recognition)
• Workup
• Initial management
• Management by diagnosis
• Follow-up
• Patient instructions
• Smartphrase snippets

Red flags / send to ED#

• Rapid weight gain with dyspnea, orthopnea, edema → possible heart failure decompensation → ED
• Rapid weight gain with decreased urine output → possible renal failure → ED
• Rapid weight gain with abdominal distension → possible ascites, malignancy → urgent evaluation
• Cushing’s syndrome with severe hypertension or hypokalemia → urgent endocrinology

Note: Most weight gain presentations are not emergencies. Red flags relate to fluid retention or serious underlying disease, not adiposity.

Key history#

Characterize the weight gain:

• Amount gained (pounds/kg)
• Timeline (weeks, months, years)
• Pattern (gradual vs rapid)
• Intentional vs unintentional
• Previous weight history, highest/lowest adult weight
• Previous weight loss attempts and outcomes

Lifestyle factors:

• Dietary habits (meal frequency, portion sizes, snacking, beverages)
• Physical activity level (type, frequency, duration)
• Sleep (duration, quality, snoring/apnea symptoms)
• Stress, emotional eating
• Alcohol intake (high calorie)
• Smoking cessation (common cause of weight gain)

Medication review (common culprits):

• Antipsychotics (olanzapine, clozapine, quetiapine, risperidone)
• Antidepressants (mirtazapine, paroxetine, amitriptyline)
• Mood stabilizers (lithium, valproate)
• Anticonvulsants (valproate, gabapentin, pregabalin)
• Diabetes medications (insulin, sulfonylureas, TZDs)
• Corticosteroids
• Beta-blockers (modest effect)
• Antihistamines (modest effect)
• Hormonal contraceptives (variable, often minimal)

Symptoms suggesting secondary cause:

• Fatigue, cold intolerance, constipation → hypothyroidism
• Easy bruising, striae, proximal weakness → Cushing’s syndrome
• Menstrual irregularities, hirsutism, acne → PCOS
• Snoring, daytime sleepiness → sleep apnea
• Edema, dyspnea → heart failure, renal disease
• Depression, anhedonia → depression-related weight gain

Medical history:

• Diabetes, prediabetes
• Cardiovascular disease
• Sleep apnea
• PCOS
• Thyroid disease
• Depression, anxiety, eating disorders
• Prior bariatric surgery

Family history:

• Obesity
• Diabetes
• Cardiovascular disease

Social history:

• Food security
• Living situation (who prepares meals)
• Work schedule (shift work affects eating patterns)
• Socioeconomic factors affecting food choices

Focused exam#

Vital signs:

• Weight, height, BMI
• Blood pressure (obesity associated with hypertension)
• Waist circumference (>40 inches men, >35 inches women = increased cardiometabolic risk)

BMI classification:

• <18.5: Underweight
• 18.5-24.9: Normal
• 25-29.9: Overweight
• 30-34.9: Obesity class I
• 35-39.9: Obesity class II
• ≥40: Obesity class III (severe)

General:

• Fat distribution (central/truncal vs peripheral)
• Moon facies, buffalo hump (Cushing’s)
• Acanthosis nigricans (insulin resistance)

Skin:

• Striae (purple/wide = Cushing’s; white/narrow = simple obesity)
• Hirsutism (PCOS, Cushing’s)
• Acne
• Easy bruising (Cushing’s)
• Dry skin (hypothyroidism)

Head/neck:

• Thyroid (goiter, nodules)
• Facial plethora (Cushing’s)
• Periorbital edema (hypothyroidism)

Cardiovascular:

• Edema (heart failure, venous insufficiency)
• JVD

Abdomen:

• Central adiposity
• Hepatomegaly (NAFLD)
• Ascites

Extremities:

• Proximal muscle weakness (Cushing’s—have patient rise from squat)
• Edema

Neurologic:

• Delayed reflexes (hypothyroidism)

Differential (quick pattern recognition)#

Common/likely (outpatient)#

Can’t-miss / urgent#

Workup#

Routine for patients with obesity (BMI ≥30) or overweight with comorbidities:

Additional tests based on clinical suspicion:

When NOT to order:

• Extensive endocrine workup for typical obesity without red flags
• Thyroid testing if recently checked and normal
• Cushing’s workup without clinical features (striae, weakness, easy bruising)

Cushing’s screening:

• First-line: 24-hour urine free cortisol OR late-night salivary cortisol (2 samples) OR 1 mg overnight dexamethasone suppression test
• If abnormal: refer to endocrinology for confirmation and localization
• Do NOT attempt to diagnose or manage Cushing’s in primary care

Initial management#

Approach to obesity treatment:

1. Address secondary causes if present
2. Lifestyle intervention (foundation for all patients)
3. Pharmacotherapy (if BMI criteria met and lifestyle insufficient)
4. Bariatric surgery referral (if BMI criteria met)

Lifestyle intervention (all patients):

• Reduced calorie diet (500-750 kcal/day deficit)
• Increased physical activity (150+ min/week moderate intensity)
• Behavioral strategies (self-monitoring, stimulus control, stress management)
• Consider referral to dietitian, behavioral health, or structured program

When to consider anti-obesity medications:

• BMI ≥30, OR
• BMI ≥27 with weight-related comorbidity (diabetes, hypertension, dyslipidemia, sleep apnea)
• After lifestyle intervention alone insufficient

When to refer for bariatric surgery:

• BMI ≥40, OR
• BMI ≥35 with weight-related comorbidity
• Failed medical weight loss attempts
• Patient motivated and understands lifelong commitment

Management by diagnosis#

Primary obesity#

Education:

• Obesity is a chronic disease, not a character flaw
• Sustainable weight loss is 1-2 lbs/week
• 5-10% weight loss significantly improves health outcomes
• Long-term maintenance requires ongoing effort
• Medications and surgery are tools, not failures

Treatment:

Lifestyle (first-line for all):

• Caloric deficit: 500-750 kcal/day below needs
• Diet quality: emphasize whole foods, vegetables, lean protein; reduce processed foods, sugar-sweetened beverages
• Physical activity: 150-300 min/week moderate intensity; resistance training 2x/week
• Behavioral support: food diary, regular weigh-ins, identify triggers

Pharmacotherapy:

Choosing anti-obesity medication:

• Most effective: Tirzepatide > semaglutide > liraglutide
• Cost-sensitive: Phentermine (short-term), orlistat (OTC)
• Diabetes comorbidity: Semaglutide or tirzepatide (also treat diabetes)
• Depression comorbidity: Naltrexone-bupropion (bupropion component)
• Avoid if: History of eating disorder (most agents); seizure (bupropion); opioid use (naltrexone)

GLP-1 RA counseling:

• Start low, titrate slowly to minimize GI side effects
• Nausea, vomiting, diarrhea common initially; usually improve
• Eat smaller portions; stop eating when full
• Weight regain common if medication stopped
• Not covered by all insurance; patient assistance programs available

Insurance and access issues:

• Many insurers exclude weight loss medications; check coverage before prescribing
• Manufacturer savings cards and patient assistance programs available (check manufacturer websites)
• Prior authorization often required; document BMI, comorbidities, failed lifestyle intervention
• Avoid compounded semaglutide/tirzepatide: FDA has warned about safety concerns with compounded versions; efficacy and sterility not guaranteed

Follow-up: Monthly during titration; then every 3 months once stable.

Medication-induced weight gain#

Approach:

1. Confirm temporal relationship
2. Assess if medication can be changed
3. If medication necessary, add lifestyle intervention ± anti-obesity medication

Common substitutions:

Note: Medication changes require coordination with prescribing provider; psychiatric medications especially require careful transition.

Hypothyroidism-related weight gain#

Key points:

• Hypothyroidism causes modest weight gain (typically 5-10 lbs), mostly fluid
• Treating hypothyroidism alone rarely causes significant weight loss
• If significant obesity, treat both hypothyroidism AND obesity

Management: Levothyroxine per hypothyroid guidelines; add obesity treatment if needed.

PCOS-related weight gain#

Key points:

• Insulin resistance central to PCOS pathophysiology
• Weight loss improves all PCOS symptoms
• 5-10% weight loss can restore ovulation

Management:

• Lifestyle intervention (first-line)
• Metformin (improves insulin resistance; modest weight effect)
• GLP-1 RA (off-label but effective for weight and metabolic parameters)
• Refer to GYN/endocrinology for comprehensive management

Cushing’s syndrome#

Recognition:

• Central obesity with thin extremities
• Purple striae (>1 cm wide)
• Proximal muscle weakness
• Easy bruising, thin skin
• Hypertension, diabetes
• Moon facies, buffalo hump

PCP role:

• Screen with 24-hour urine cortisol or late-night salivary cortisol
• If abnormal, refer to endocrinology
• Do NOT attempt to diagnose or treat in primary care

Treatment: Depends on cause (pituitary adenoma, adrenal tumor, ectopic ACTH); managed by endocrinology/surgery.

Follow-up#

Lifestyle intervention alone:

• Monthly for first 3 months (accountability, troubleshooting)
• Then every 3 months

On anti-obesity medication:

• Monthly during titration
• Every 3 months once stable
• Assess efficacy at 12-16 weeks; if <5% weight loss, reassess

After bariatric surgery:

• Managed by bariatric surgery team initially
• PCP role: monitor for nutritional deficiencies, medication adjustments, long-term complications

Return precautions:

• Rapid weight gain (>5 lbs in a week) with swelling or shortness of breath
• Symptoms of medication side effects
• Mood changes, suicidal thoughts (some medications)
• Signs of gallbladder disease (common with rapid weight loss)

Patient instructions#

• Weight gain often results from many factors including genetics, metabolism, lifestyle, medications, and medical conditions.
• Losing weight is challenging, but even modest weight loss (5-10% of your body weight) can significantly improve your health.
• Focus on sustainable changes rather than quick fixes. Aim for 1-2 pounds per week.
• Eat more vegetables, fruits, lean proteins, and whole grains. Reduce sugary drinks, processed foods, and large portions.
• Aim for at least 150 minutes of moderate physical activity per week (like brisk walking).
• Keep a food diary to become aware of what and how much you’re eating.
• Get enough sleep (7-9 hours) and manage stress—both affect weight.
• If lifestyle changes aren’t enough, medications or surgery may be options. These are tools to help, not signs of failure.
• Avoid fad diets or supplements that promise rapid weight loss—they rarely work long-term and can be harmful.

Smartphrase snippets#

.OBESITYEVAL Weight management evaluation. Current weight [X] lbs, BMI [X]. Weight history: [highest weight, recent changes]. Lifestyle assessment: [diet patterns, activity level, sleep, stress]. Medications reviewed for weight effects: [list any culprits]. No symptoms suggesting secondary cause (hypothyroidism, Cushing’s). Labs: [TSH normal, A1c X, lipids X]. Assessment: Primary obesity, class [I/II/III]. Plan: Lifestyle intervention with [caloric goal, activity goal]. [Consider anti-obesity medication given BMI criteria / Discussed bariatric surgery referral]. Follow-up in [4 weeks].

.OBESITYMEDS Initiating anti-obesity pharmacotherapy. BMI [X] with [comorbidities]. Lifestyle intervention ongoing with [X lbs] weight loss to date. Starting [medication] at [starting dose], will titrate per protocol. Discussed expected weight loss (~X%), common side effects [GI symptoms/etc.], and need for ongoing lifestyle changes. [If GLP-1: Counseled on slow titration, eating smaller portions, and that weight regain is common if medication stopped.] Follow-up in 4 weeks for tolerability and dose titration.

.WEIGHTGAINSECONDARY Evaluation for secondary causes of weight gain. Patient reports [X lbs] gain over [timeframe] with [associated symptoms]. Exam notable for [findings or normal]. Workup: [TSH, cortisol testing, etc.]. [If positive: Diagnosis of X; plan for treatment/referral.] [If negative: No secondary cause identified; weight gain likely related to [lifestyle factors/medications]. Plan for obesity management as above.]

Related pages#

• Obesity (problem) — comprehensive management of obesity as a chronic disease
• Hypothyroid symptoms — hypothyroidism as secondary cause of weight gain
• Hyperglycemia symptoms — diabetes often comorbid with obesity
• Depression — depression-related weight gain
• Edema — fluid retention vs adiposity
• Obstructive sleep apnea (problem) — obesity-related sleep apnea
• Hypertension (problem) — obesity-related hypertension
• Hyperlipidemia (problem) — metabolic syndrome component

Coding/billing notes#

• E66.9: Obesity, unspecified
• E66.01: Morbid (severe) obesity due to excess calories
• E66.1: Drug-induced obesity
• E66.3: Overweight
• Z68.30-Z68.45: BMI codes (use as secondary diagnosis)
• E24.9: Cushing’s syndrome, unspecified
• E28.2: Polycystic ovarian syndrome
• E03.9: Hypothyroidism, unspecified